Ladenburg Thalmann Starts InVivo Therapeutics (NVIV) at Buy
Tweet
Share
E-mailGet Alerts NVIV Hot Sheet
Price: $0.32 --0%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
Ladenburg Thalmann initiated coverage on InVivo Therapeutics (NASDAQ: NVIV) with a Buy rating and a price target of $23.25.
For an analyst ratings summary and ratings history on InVivo Therapeutics click here. For more ratings news on InVivo Therapeutics click here.
Shares of InVivo Therapeutics closed at $6.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Starts AFLAC (AFL) at Underperform
- Oppenheimer Starts Healthcare Services Group (HCSG) at Outperform
- Goldman Sachs Assumes Cricut, Inc. (CRCT) at Sell
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
